TellWell
← Back to feed
Health6h ago58% confidenceConfidence 58% — the share of independent, credible sources corroborating the core facts.

Biohacker Dave Asprey Advocates for Strategic Carbohydrate Consumption Rather Than Elimination

1 source

Dave Asprey, founder of the biohacking movement, argues that carbohydrates should not be avoided entirely and that he maintains low body fat while eating carbs regularly by following specific rules. The anti-carb movement gained prominence in the 1970s with Dr. Robert Atkins' ketosis theory and resurged in the 1990s, but Asprey now distances himself from strict keto diets. His approach emphasizes selecting low-toxin carbs, preparing them correctly, and pairing them strategically to avoid blood sugar spikes and weight gain.

Dave Asprey, founder of the biohacking movement, challenges the decades-long demonization of carbohydrates in America, arguing that the problem lies not with carbs themselves but with how people consume them. Asprey, who maintains 6.5-7% body fat while eating carbs daily, previously championed the high-fat, low-carb "Bulletproof diet" and helped popularize intermittent fasting and cyclical ketosis, but now advocates against strict keto diets, citing research showing they can elevate cholesterol, increase arterial plaque-building compounds, and harm gut bacteria. He recommends three key strategies: choosing low-toxin carbs like white rice and low-fructose fruits over wheat and ultra-processed grains; preparing carbs correctly through methods like cooling cooked rice to create resistant starch; and pairing carbs strategically with foods like MCT oil. While acknowledging that some research supports keto diets for specific conditions like drug-resistant epilepsy, Asprey contends that most people benefit from including at least some carbohydrates in their diet.

What's missing

The article relies heavily on Asprey's personal claims and recommendations without substantial independent scientific validation. While one study on keto diet effects is cited, broader peer-reviewed evidence comparing Asprey's specific carb-selection and preparation methods to conventional nutritional guidance is not presented. The long-term health outcomes of his approach are not documented.

What different sources said

  • How to eat carbs like a biohacker — without gaining weight

Related

HealthConfidence 88% — the share of independent, credible sources corroborating the core facts.

Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction

Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.

1 source8m ago
HealthConfidence 82% — the share of independent, credible sources corroborating the core facts.

Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research

Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.

1 source38m ago
HealthConfidence 58% — the share of independent, credible sources corroborating the core facts.

GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations

Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.

1 source38m ago